APSR2026-849

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-015
P92
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221078-46904-APSR AP12-015_440641.pdf
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Nurul Aimi Abd Ghani * Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
Syazatul Syakirin Sirol Aflah - Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
Kezreen Kaur Dhaliwal - Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
Nik Nur Amirah Nik Abeed - Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Nurul Aimi
Abd Ghani
nurulaimi317@gmail.com
+60133335991
31-40
Malaysia
Original Research
Bridging the Diagnostic Gap: The Impact of a Virtual Multidisciplinary Discussion In Interstitial Lung Disease Diagnosis and Treatment Recommendations
Maximum 25 words
Abstract Content
Multidisciplinary Discussion (MDD) is universally recognized as the gold standard for interstitial lung disease (ILD) diagnosis and management. However, formal guidelines offer limited technical directives on implementation; consequently, the operational structure of an MDD including panellist composition, meeting frequency, and platform is often adapted to a centre’s specific resources, timing, and facilities. Despite this variability, the real-world impact of these adapted MDD frameworks on diagnosis and treatment decisions, remains to be fully elucidated.
A retrospective analysis was conducted on ILD cases presented in MDD at virtual platform coordinated by Institut Perubatan Respiratori (IPR) from January 2024 to December 2025. The discussion include the state-level pulmonologists, thoracic radiologists, and rheumatologists. Consensus decisions were documented in written reports to track before and after MDT diagnostic discrepancies and treatment recommendation.
A total of 567 cases were included (2024: n=279; 2025: n=288). All were discussed to confirm the ILD diagnosis, and diagnostic reclassification occurred in 35% of patients, with consistency across both years (p=0.62). MDD discussion was significantly more likely to yield a recommendation for therapeutic intervention in cases involving diagnostic change compared to those with unchanged diagnoses (62% vs 48%, p=0.01). While the prevalence of progressive pulmonary fibrosis (PPF) increased significantly in 2025 (p=0.004), there was no corresponding change in treatment recommendations (p=0.181), with Nintedanib remaining the primary suggested therapy across the study period. Collectively, these results demonstrate that MDD-led diagnostic refinement and PPF identification are the fundamental element for optimising clinical management recommendations.
MDD discussion establishes a rigorous consensus-based framework that enhances diagnostic confidence and identifies disease progression. By facilitating the diagnosis establishment, the MDD provides essential clinical justification for timely and evidence-based treatments. This systemic approach ensures diagnostic refinement remains the primary catalyst for appropriate treatment recommendation.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
multidisciplinary, interstitial lung
maximum 3 keywords and no abbreviations, separated by commas
Nil
296